Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
22.33
-3.01 (-11.88%)
At close: Mar 27, 2026, 4:00 PM EDT
22.23
-0.10 (-0.45%)
After-hours: Mar 27, 2026, 7:49 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $309.37 million as of March 27, 2026. Its market cap has increased by 99.80% in one year.
Market Cap
309.37M
Enterprise Value
305.56M
1-Year Change
99.80%
Ranking
Category
Stock Price
$22.33
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $309.37M, an increase of 350.40%. That is a compound annual growth rate of 31.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 309.37M | 6.28% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 364.60M |
| XOMA Royalty | 363.48M |
| Enanta Pharmaceuticals | 363.03M |
| Niagen Bioscience | 357.96M |
| Candel Therapeutics | 357.45M |
| DiaMedica Therapeutics | 356.73M |
| Autolus Therapeutics | 343.32M |
| Armata Pharmaceuticals | 342.52M |